MCP-1 reported the highest excellent diagnostic accuracy percentage for NHL and HL (94.7 and 93.75%, respectively) at indicated cut-off levels with a corresponding high sensitivity (94.4 and 91.7%, respectively). This evidence concerns the gene CCL2 and non-Hodgkin lymphoma.